Similar articles

• Serum thromboxane in the horse and its inhibition by aspirin, phenylbutazone and flunixin.

  Lees P, Ewins CP, Taylor JB, Sedgwick AD. Lees P, et al. Br Vet J. 1987 Sep-Oct;143(5):462-76. doi: 10.1016/0007-1935(87)90024-8. Br Vet J. 1987. PMID: 3119142 No abstract available.
• COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis.

  Beretta C, Garavaglia G, Cavalli M. Beretta C, et al. Pharmacol Res. 2005 Oct;52(4):302-6. doi: 10.1016/j.phrs.2005.04.004. Pharmacol Res. 2005. PMID: 15939622
• Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.

  Semrad SD, Sams RA, Harris ON, Ashcraft SM. Semrad SD, et al. Am J Vet Res. 1993 Nov;54(11):1901-5. Am J Vet Res. 1993. PMID: 8291770
• Effects of flunixin meglumine, phenylbutazone and a selective thromboxane synthetase inhibitor (UK-38,485) on thromboxane and prostacyclin production in healthy horses.

  Hardee MM, Moore JN, Hardee GE. Hardee MM, et al. Res Vet Sci. 1986 Mar;40(2):152-6. Res Vet Sci. 1986. PMID: 3517992
• Experimental uses of flunixin meglumine and phenylbutazone in food-producing animals.

  Kopcha M, Ahl AS. Kopcha M, et al. J Am Vet Med Assoc. 1989 Jan 1;194(1):45-9. J Am Vet Med Assoc. 1989. PMID: 2644181 Review.